In Case You Missed the Show: #MayoClinicRadio Podcast 10/17/15
Listen: Mayo Clinic Radio podcast 10-17-15 On Mayo Clinic Radio, breast cancer specialist Dr. Sandhya Pruthi discusses the latest in diagnosis and treatment, including the debate over whether ductal carcinoma in situ (DCIS) is an early form of breast cancer. Also on the program, by age 80 more than half of all Americans either have [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 19, 2015 Category: Databases & Libraries Source Type: news
Molecular Drivers of Lobular Carcinoma in SituMolecular Drivers of Lobular Carcinoma in Situ
Is lobular carcinoma in situ a precursor to invasive lobular carcinoma? Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 15, 2015 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Husband And Wife Both With Breast Cancer Show It Isn't Just A Woman's Disease
An inspirational couple has turned a shared illness into a shared vision for the future of public health. Meg and Gerard Campion have both been diagnosed with breast cancer over the past decade, and today are relentlessly raising awareness for the disease, particularly among men, ABC News reported. Breast cancer first affected the Connecticut couple when Gerard was diagnosed with the disease in 2006, after noticing a bump on his chest. “It was obviously shocking,” Meg told the news outlet. “I think my first thought was, 'He’s not supposed to have this, I am.'” Just three years later, ...
Source: Science - The Huffington Post - October 12, 2015 Category: Science Source Type: news
Ductal carcinoma in situ treatments evolve over 20 years, but cancer death rates vary little
Treatment patterns for ductal carcinoma in situ (DCIS) have shifted since the 1990s, with more U.S. women opting for lumpectomy in combination with radiation rather than single-breast mastectomy, according to a study. But the researchers also found an increased tendency for women to seek removal of both breasts, despite their analysis that cancer survival rates remained similar regardless of the form of treatment. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 10, 2015 Category: Science Source Type: news
Galena and NCI to start Phase II trial NeuVax to treat ductal carcinoma in Situ patients
US-based biopharmaceutical firm Galena Biopharma has entered into a collaboration with the National Cancer Institute (NCI) to start a new, Phase II clinical trial with NeuVax (nelipepimut-S) in patients diagnosed with ductal carcinoma in situ (DCIS). (Source: Drug Development Technology)
Source: Drug Development Technology - October 1, 2015 Category: Pharmaceuticals Source Type: news
DCIS Surgery Outcomes Have Improved over Time (CME/CE)
(MedPage Today) -- Recurrence rates of ductal carcinoma in situ at MSKCC fell by half (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 25, 2015 Category: Hematology Source Type: news
Untangling the non-invasive breast cancer controversy
In this study, approximately 500 patients died of breast cancer without ever having invasive cancer in the breast. This suggests that for some very small subset of women, distant or metastatic disease occurred despite treatment of DCIS — a concerning finding.
Also, death rates were higher for women diagnosed with DCIS before the age of 35, and for black women compared to non-Hispanic white women. This suggests that these women may need more aggressive intervention.
The good news: The study also reaffirmed the fact that overall, mortality associated with DCIS is exceedingly low. Fewer than 1% of patients in this 20-year s...
Source: New Harvard Health Information - September 18, 2015 Category: Consumer Health News Authors: Sara Fazio, MD, FACP Tags: Breast Cancer Tests and procedures DCIS ductal carcinoma in situ Non-invasive Breast Cancer Source Type: news
20-year follow-up of academic EORTC boost no-boost trial earns Best Abstract at ECC 2015
(European Organisation for Research and Treatment of Cancer) Results of a 20-year follow-up of the academic EORTC 22881-10882 boost no-boost trial presented as a 'Best Abstract' at the European Cancer Congress 2015 in Vienna show that young age, high-grade invasive tumor, and the presence of associated ductal carcinoma in situ were all factors increasing the local recurrence rate. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 14, 2015 Category: Cancer & Oncology Source Type: news
Has Mammography Created An Epidemic Of Pseudo-Survivorship?
Karen Vogt’s breast cancer journey began like many others, with her breasts painfully squeezed into a mammography machine. At age 52, it was far from her first mammogram, but this scan would be the most consequential by far. It revealed microcalcifications, little areas of breast tissue speckled with deposits of calcium that her radiologist worried were suspicious for a nascent cancer, especially since these specks hadn’t been so conspicuous twelve months earlier. A biopsy proved that the radiologist’s suspicions were warranted. Vogt had a small cancer in her left breast, a ductal carcinoma in situ, as he...
Source: Forbes.com Healthcare News - September 8, 2015 Category: Pharmaceuticals Authors: Peter Ubel Source Type: news
Kopans: JAMA Oncology paper misinterprets DCIS data
Just how deadly is ductal carcinoma in situ (DCIS)? A paper by Narod et al...Read more on AuntMinnie.comRelated Reading:Study: DCIS is more deadly than thought, August 20, 2015Digital mammography finds DCIS most likely to become cancer, April 16, 2014Quantitative 3D image analysis enables DCIS staging, December 16, 2013NCBC: Does DCIS need to be treated?, March 26, 2013FFDM better for DCIS -- and it doesn't cause 'overdiagnosis', October 2, 2012 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 24, 2015 Category: Radiology Source Type: news
Is early breast cancer over treated?
More than 60% of all women over 40 in the United States have had a mammogram in the past two years. And 20% of mammograms detect something called ductal carcinoma in situ, or DCIS -- also known as Stage 0 breast cancer. (Source: WDSU.com - Health)
Source: WDSU.com - Health - August 24, 2015 Category: Consumer Health News Source Type: news
Breast Cancer Treatment and D.C.I.S.: Readers React
An article Thursday about treatment for ductal carcinoma in situ prompted a wide range of responses, anger, sadness and relief among them. (Source: NYT Health)
Source: NYT Health - August 21, 2015 Category: Consumer Health News Authors: LELA MOORE Tags: Mastectomy Women and Girls Cancer Breast Cancer Source Type: news
Some women more susceptible to rare early breast cancer
Stephen FellerWASHINGTON, Aug. 21 (UPI) -- A new study found that younger women and black women have a greater chance of being diagnosed with ductal carcinoma in situ, an early form of breast cancer. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 21, 2015 Category: Consumer Health News Source Type: news
1000s of breast cancer patients have surgery 'needlessly'
About 80 per cent of the 4,600 British women diagnosed with ductal carcinoma in situ elect to have surgery - which can involve removing one or both breasts. (Source: the Mail online | Health)
Source: the Mail online | Health - August 21, 2015 Category: Consumer Health News Source Type: news
Aggressive Treatment of Ductal Carcinoma in Situ Does Not Reduce Death from Breast Cancer (FREE)
By Cara Adler
Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS
Preventing breast cancer recurrences in women with ductal carcinoma in situ (DCIS) does not lower their 10-year risk for death from breast cancer, a JAMA Oncology study finds.Researchers examined U.S. registry data … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 21, 2015 Category: Primary Care Source Type: news
